Want to see KR:017180 full AI Analyst Report?
MYUNGMOON Pharm Co., Ltd. (017180) Income Statement
MYUNGMOON Pharm Co., Ltd. Income Statement
Last quarter (Q2 2026), MYUNGMOON Pharm Co., Ltd.'s total revenue was $51.21B, an increase of 5.03% from the same quarter last year. In Q2, MYUNGMOON Pharm Co., Ltd.'s net income was $-1.26B. See MYUNGMOON Pharm Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 195.25B | $ 186.44B | $ 169.57B | $ 152.13B | $ 137.76B | |
| $ 107.19B | $ 104.97B | $ 95.35B | $ 78.10B | $ 62.34B | |
| $ 100.36B | $ 103.04B | $ 94.39B | $ 71.67B | $ 68.22B | |
| Depreciation and Amortization | $ 3.29B | $ 4.07B | $ 4.17B | $ 4.24B | $ 4.20B |
| $ 10.13B | $ 5.67B | $ 4.52B | $ 10.63B | $ 790.68M | |
| $ 6.83B | $ 1.93B | $ 963.77M | $ 6.43B | $ -5.88B | |
| $ -4.19B | $ -5.67B | $ -5.75B | $ -3.78B | $ -717.32M | |
| $ 2.65B | $ -3.74B | $ -4.78B | $ 2.65B | $ -6.60B | |
| $ 1.90B | $ -3.03B | $ -4.52B | $ 7.87B | $ -6.80B | |
| Per Share Metrics | |||||
| Basic EPS | $ 56.70 | $ -90.62 | $ -134.35 | $ 232.74 | $ -201.27 |
| Diluted EPS | $ 56.70 | $ -90.62 | $ -134.35 | $ 232.74 | $ -201.27 |
| Weighted Average Shares Outstanding | 33.95M | 33.48M | 33.68M | 33.81M | 33.81M |
| Weighted Average Shares Outstanding (Diluted) | 33.95M | 33.48M | 33.68M | 33.81M | 33.81M |
Currency in KRW
